The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium.

Kho, Marcia M LReinders, Marlies E JBaan, Carla Cvan Baarle, DebbieBemelman, Frederike JDiavatopoulos, Dimitri AGansevoort, Ron Tvan der Klis, Fiona R MKoopmans, Marion P GMesschendorp, A Liannevan der Molen, Renate GRemmerswaal, Ester B MRots, NynkeVart, Priyade Vries, Rory DHilbrands, Luuk BSanders, Jan-Stephan F2021-07-122021-07-122021-05-263403855410.1093/ndt/gfab186http://hdl.handle.net/10029/625038enThe RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium.Article1460-2385Nephrol Dial Transolant 2021; 36(9):1761-4